Doctor profile · Federal record
Dr. Paula Rosenblatt, MD
Medical Oncology Physician (CMS: Medical Oncology) · Hematology (Internal Medicine) Physician · Baltimore, MD
- NPI 1972707206
- Accepts Medicare
- MIPS 99.2 / 100 · 2023
- 19 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
22 S Greene St, S9D15B
Baltimore, MD 212011595
(410) 328-6373
fax (410) 328-6896 - Mailing address
-
22 S Greene Street, S9D15B
Baltimore, MD 212011595
Credentials & registration
- NPI registered
- June 2007 — 19 yrs on file
- Profile last updated
- May 9, 2017
- Year of graduation
- 2007 — 19 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Maryland #D70537
- Medicaid
- MD #562101100
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1972707206. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
310
Distinct HCPCS
3
Medicare allowed
$39,354
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 152 | 91 | $102 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 139 | 35 | $147 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 19 | 18 | $184 |
In context: peer comparison
Among 37 peers in Baltimore Medical Oncology Physician, average services per provider: 1,726. This provider delivers 0.2× the peer median.Open Payments
Industry payments received
All-time total
$1,322
Transactions
30
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $889.12 | |
| Gilead Sciences, INC. | 6 | $117.62 | |
| Abbvie INC. | 3 | $85.64 | |
| Daiichi Sankyo INC. | 3 | $81.58 | |
| Genentech USA, INC. | 2 | $50.66 | |
| AstraZeneca Pharmaceuticals Lp | 2 | $48.68 | |
| Merck Sharp & Dohme LLC | 1 | $26.46 | |
| Pfizer INC. | 1 | $22.01 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
395
Patients
70
Total drug cost
$434,596
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 113 | 41 | $3,628 |
| Exemestane | Generic | 41 | 17 | $12,767 |
| Anastrozole | Generic | 35 | 12 | $887 |
| Oxycodone Hcl | Generic | 34 | 0 | $548 |
| Eliquis (Apixaban) | Brand | 33 | 0 | $25,210 |
| Gabapentin | Generic | 17 | 0 | $232 |
| Ondansetron Hcl | Generic | 16 | 0 | $104 |
| Morphine Sulfate ER (Morphine Sulfate) | Brand | 15 | 0 | $903 |
| Potassium Chloride | Generic | 15 | 0 | $254 |
| Everolimus | Generic | 14 | 0 | $140,326 |
Hospital affiliations
Frequently asked questions
What is Dr. Paula Rosenblatt's medical specialty?
Dr. Paula Rosenblatt practices Medical Oncology Physician in Baltimore, MD.
Where does Dr. Paula Rosenblatt practice?
Dr. Paula Rosenblatt practices at 22 S Greene St, Baltimore, MD 212011595. Office phone: 4103286373.
What is Dr. Paula Rosenblatt's NPI?
Dr. Paula Rosenblatt's National Provider Identifier (NPI) is 1972707206, issued by NPPES.
Does Dr. Paula Rosenblatt accept Medicare assignment?
Yes. Dr. Paula Rosenblatt accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Paula Rosenblatt commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99215); Initial hospital care with moderate level of medical decision making (HCPCS 99223). Source: CMS Medicare Physician & Other Practitioners file.